Arthritis Australia and Juvenile Arthritis Foundation Australia
On Tuesday, 21st
March 2023, Arthritis Australia and the Juvenile
Arthritis Foundation Australia (JAFA)
issued a media release warning of a looming crisis in arthritis that could hit the community and the economy hard. The media release comes
at a time when the number of people living with arthritis is expected to rise, causing significant impacts on the quality of life of
individuals and their families.
According to the release, arthritis is a leading cause of disability, with more than 3.6 million people, of all ages, affected in
Australia alone. Arthritis, and other musculoskeletal conditions, causes chronic pain, stiffness, and inflammation in the joints, making it
difficult for people to carry out their daily activities. The media release identified approximately 43% of young people (0-16 years) with
arthritis have no access to specialist multidisciplinary healthcare and 80% experience pain daily (1,2).
The economic costs of arthritis are substantial, with estimates suggesting that the condition costs the Australian economy more than $23
billion each year in lost productivity and healthcare costs.
More than $1.4 billion a year is spent on knee replacements due to osteoarthritis - it is identified that $200 million of this could be avoided if those at risk had access to earlier interventions (3). Knee and hip replacements are expected to double to $5.3 billion per year by 2030 (3).
The crisis in arthritis is being driven by several factors, as highlighted by the media release:
To address the crisis in arthritis, Arthritis Australia and JAFA calls for urgent action from the government and policymakers to seek action on three priority areas:
The media release also calls for the prioritisation of the needs of people living with arthritis in health policy, to reduce the economic
burden of the condition. Musculoskeletal conditions including arthritis received 60% lower funding from the National Health and Medical
Research Council in 2021 when compared to cardiovascular disease or mental health (5), There is no dedicated Medical Research Future
Fund for musculoskeletal conditions, whereas $220 million was put into cardiovascular disease and a further $125 million in mental
health - which carry similar burdens (6).
In conclusion, the media release from Arthritis Australia and JAFA highlights
the urgent need for action to address the growing crisis in arthritis. With millions of people affected by this debilitating condition, it
is essential that we work together to improve awareness, increase support, and invest in research and treatment options that will improve
the lives of those living with arthritis. It is time for the government and policymakers to prioritise the needs of people with arthritis to
ensure a better quality of life for all.
For
more information read the full media release here.
Source:
1. Cox A, Piper S, and Singh-Grewal D. Pediatric rheumatology consultant workforce in Australia and New Zealand: the current state of play
and challenges for the future. Int J Rheumatic Diseases 2017; 20: 647–65
2. Model of Care for the NSW Paediatric Rheumatology Network, Agency for Clinical Effectiveness, 2013. Accessed March 2023
3. Counting the Cost: Current and Future Burden of Arthritis, Arthritis Australia, May 2016. Accessed March 2023
4. Rheumatology Workforce Report’, Australian Rheumatology Association, February 2023. Accessed March 2023
5. National Health and Medical Research Council research funding statistics 2013-2021. Accessed March 2023
6. National Health and Medical Research Council expenditure 2021. Accessed March 2023
You can make a difference by supporting the work of Arthritis Queensland. Arthritis Queensland is 95% community funded. We rely on our generous donors and volunteers to ensure that we can continue to provide solutions and support to adults and children living with the pain of arthritis.